1. KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer. Issue 4 (12th September 2012) Authors: Mao, Chen; Huang, Ya‐Fang; Yang, Zu‐Yao; Zheng, Da‐Yong; Chen, Jin‐Zhang; Tang, Jin‐Ling Journal: Cancer Issue: Volume 119:Issue 4(2013) Page Start: 714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Promising biomarkers for predicting the outcomes of patients with KRAS wild‐type metastatic colorectal cancer treated with anti‐epidermal growth factor receptor monoclonal antibodies: A systematic review with meta‐analysis. Issue 8 (13th July 2013) Authors: Yang, Zu‐Yao; Wu, Xin‐Yin; Huang, Ya‐Fang; Di, Meng‐Yang; Zheng, Da‐Yong; Chen, Jin‐Zhang; Ding, Hong; Mao, Chen; Tang, Jin‐Ling Journal: International journal of cancer Issue: Volume 133:Issue 8(2013:Oct. 15) Page Start: 1914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗